Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronie's Disease
Date:10/11/2010

MALVERN, Pa., Oct. 11 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced that the first subject has been dosed in the global phase III program of XIAFLEX® for the treatment of Peyronie's disease.  Peyronie's disease is the development of scar tissue on the penis that can cause the penis to curve during erection, often interfering with or preventing intercourse and resulting in psychological distress or bother for the patient.

"Peyronie's disease is a devastating disease that is estimated to affect approximately 5% of adult men and, therefore, we are pleased to be moving forward into the phase III development of XIAFLEX,"  said Armando Anido, Chief Executive Officer and President of Auxilium. "We believe that there is significant unmet medical need for a nonsurgical alternative for Peyronie's disease, and we have been encouraged by the enthusiasm that we have perceived among the urology community and their prospective patients for participating in our phase III program. We anticipate completing enrollment for the double-blind studies in the first quarter of 2011 and reporting top-line results in first half of 2012."  

Our late stage global development plan for XIAFLEX will consist of four clinical studies and will be known by the acronym IMPRESS – The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies.  There will be two randomized, double-blind, placebo-controlled phase III studies, which are expected to enroll at least 600 patients at approximately 70 sites in the U.S. and Australia, with a 2:1 ratio of XIAFLEX to placebo.  There also will be one open label study, which is expected to enroll at least 250 patients, at approximately 30 sites in the U.S., EU and New Zealand, and one pharmacokinetic study, which should enroll approximately 16 pat
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Advanced Prenatal Therapeutics (APT), a privately held ... alleviate the high blood pressure and other symptoms associated ... be the first medical device specifically designed to treat ... Every year, preeclampsia affects approximately 300,000 pregnant ... It is characterized by high blood pressure and proteinuria ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 /PRNewswire/ ... is investigating potential claims on behalf of purchasers ... or the "Company") (NasdaqGS: AMAG -News).  The investigation ... violated federal securities laws. On May ... 10.73% during intraday trading after the company announced ...
(Date:5/22/2013)... 2013  The Leukemia & Lymphoma Society (LLS) is ... LLC, a joint venture between ImmunGene and Caliber, to ... Phase I clinical trial for a novel fusion protein ... patients with indolent lymphomas who do not respond to ... IGN002, is a new class of biotherapeutics produced by ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... 2012  Niagara Thermal Products LLC is pleased to announce ... acquisition brings together two highly regarded names in the ... in the aerospace, defense and electronics markets. ... addition of Kittredge,s industry recognized dip brazing, welding, machining ...
... N.C., Jan. 23, 2012  As the influence of Managed ... that biopharma companies carry out as part of interacting ... device leaders have placed an increased importance on these ... closely intertwined with marketplace success. On average, ...
Cached Medicine Technology:Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 2Niagara Thermal Products LLC Announces the Acquisition of J. Kittredge & Sons, Inc. 3Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations 2Pharmaceutical Industry Places Newfound Emphasis on Managed Care Organizations 3
(Date:5/22/2013)... OH (PRWEB) May 22, 2013 The ... among consumers, however cutting through marketing claims to compare ... The Sleepy Shopper, a bed blog , offers ... of leading types in their latest article. , Titled ... Benefits ”, this article guides readers through the basics ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a female ... This is the oldest yoga found in written form (in a ... partner of renowned Indian master and yogi Naropa, and the yoga ... female yoga master. , Lady Niguma taught the practice to ... a long lineage to the second Dalai Lama, Gendun Gyatso. While ...
(Date:5/22/2013)... Jury deliberations are now underway in Washington ... da Vinci lawsuit, Bernstein Liebhard LLP reports. According ... who allegedly died of da Vinci surgery complications following prostate ... from Intuitive Surgical, Inc. Among other things, they allege ... da Vinci Surgical System in its efforts to drive sales ...
(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- Anyone who ... something about feet that fungi seem to like. But ... fungal groups that live on your skin -- and, ... It,s no secret that the human body is awash ... both outside and inside. And it,s mainly a friendly ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 DePuy ... the DePuy Pinnacle Hip Replacement System continue to move ... Court, Bernstein Liebhard LLP reports. According to an ... Orthopaedics to produce monitoring reports associated with a 2007 ... medical device marketing practices. Plaintiffs maintained in their ...
Breaking Medicine News(10 mins):Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3
... March 12 Professional Healthcare Resources, Inc., a ... Virginia, Washington DC, and Maryland, is pleased to ... by CHAP (the Community Health Accreditation Program), the ... accreditation process involved an in depth review of ...
... attacks than their predecessors, researchers say , , THURSDAY, March 12 ... even when compared with their counterparts 10 or 20 years ... aging boomers are being hospitalized for heart attacks now than ... in cases could place a big burden on cardiac care ...
... Community Suggests Adult Stem Cell Advances Could Be ... Calif., March 12 Adult Stem Cell scientists ... order repealing restrictions on Embryonic Stem Cell research ... and resources away from the promising Adult Stem ...
... diverse individuals with diabetes has found that home telemonitoring of ... similar group that was not monitored. Diabetes is the ... , The study of 387 diabetics and 387 individuals without ... Journal of Telemedicine and Telecare . , The researchers, led ...
... - CRH Medical Corporation (CRM:TSX-V) announced today that its ... on the nationally syndicated television program The Doctors. The ... local listings may be found at www.thedoctorstv.com . ... the # 1 new syndicated series, will receive the ...
... NEW BRUNSWICK, N.J., March 12 ... a pre-recorded webcast for financial analysts on Sunday, March 15 ... Institute of Pain 5th World Congress (WIP) in New York ... release (ER), a novel centrally acting oral analgesic, will be ...
Cached Medicine News:Health News:Professional Healthcare's Hospice Program Receives CHAP Accreditation 2Health News:Aging Baby Boomers May Swamp Cardiac Care 2Health News:Aging Baby Boomers May Swamp Cardiac Care 3Health News:Will Obama's Stem Cell Announcement Doom Promising Adult Stem Cell Research? 2Health News:Telehealth for diabetes promotes aging at home, not in the hospital 2Health News:CRH O'Regan Hemorrhoid Banding system featured on a nationally syndicated television program 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: